The academic year 2014/2015 has come to an end, and we have gathered strength for new efforts in the next. This is a good opportunity to reflect on the performance of the European Journal of Gastroenterology and Hepatology in the previous year, which Didier Lebrec and I have edited in a joint venture since 2008. In short, we are both very pleased with the course of events and achievements and look forward to new initiatives.
It can be noted that, in 2014, the journal received 1238 new submissions (607 in hepatology and 631 in gastroenterology), of which 18.5% were finally accepted. The mean time to the first editorial decision was 12.9 days, indicating extremely fast performance in this special medical and scientific field. The editors received contributions from 1038 reviewers.
The editorial program of the European Journal of Gastroenterology and Hepatology covers clinical and translational research in gastroenterology and hepatology, including epidemiology, and also a wide range of healthcare aspects at regional, national, and international levels, with special interest in patient outcomes, particularly aspects of quality of care and quality of life.
With regard to the types of publications, there has been a trend toward a reduction in the number of case reports to accommodate more original scientific articles. In addition, to be able to cover a wider range of topics, the format ‘Short article’ has been added to the spectrum.
Submissions of meta-analyses are steadily increasing in number, and only the most clinically important ones can be accepted. As the publisher has left additional space to our disposition, we will use these pages for the meta-analyses every 3 months (selection of the articles is at the discretion of the editors).
We hope that you appreciate the recent color changes in the layout of the journal text, which should contribute to your reading pleasure. Additional features have been planned for the future.
Our work has, as always, been supported by the members of a strong and active Editorial Board, who will be invited by the end of this year to continue their important engagement.
Finally, the editors express their gratitude for the opportunities and collaborations provided to them by the publisher to promote new and exciting clinical research and opinions over the previous year, in particular addressing Anna Rutkowska for the engaged day-to-day editorial work and Dr Phil Daly for his openness to new ideas and support toward their realization.
We are glad that you, the readers, the target audience for the effort and care put into the European Journal of Gastroenterology and Hepatology, have awarded us with a further increase in impact factor to 2.253. We are very honored by this and look forward to our future ‘co-production’.